CVS Health Corp (CVS)

Health Services • Health Care

Stock AI

News & Reports

July 30, 2026 CVS Health® Shines at 2026 US Customer Experience Awards CVS Health has been recognized as the Overall Winner at the 2026 US Customer Experience Awards, securing four gold awards for its innovative use of AI, customer feedback measurement, and employee engagement. This achievement underscores CVS's commitment to customer-centric healthcare solutions and enhancing patient experience.

July 29, 2026 CVS Health's Health100™ Achieves Landmark Accreditation for Consumer Data Privacy and Security CVS Health's Health100™ app has achieved the CARIN Code of Conduct accreditation from DirectTrust, demonstrating its commitment to consumer data privacy and security. This milestone enhances the app's transparency and empowers users in their healthcare journey.

July 22, 2026 CVS Health's Commitment to Massachusetts: A Multifaceted Approach to Community Health CVS Health has launched a comprehensive initiative in Massachusetts, investing over $83 million in affordable housing and healthcare services. This includes partnerships with local nonprofits to provide free health screenings and nutritious meal programs, aiming to improve community health outcomes.

July 15, 2026 CVS Health Corp: Aetna Provider Survey Highlights Increased Trust and Digital Advancements The latest Aetna Provider Survey by CVS Health shows increased trust between healthcare providers and payers, with notable improvements in digital tool usage. Despite this progress, providers still face significant administrative burdens, particularly with patient records and prior authorizations.

July 14, 2026 CVS Health Corp Solidifies Commitment to Affordability and Transparency with FTC Settlement CVS Caremark has reached a significant settlement with the FTC aimed at improving affordability and transparency in the pharmaceutical industry. Key provisions include cost-sharing alignment and new affordability programs, such as capping insulin costs at $25/month. This settlement underscores CVS's commitment to reducing prescription drug costs and enhancing the healthcare experience for American consumers.

July 10, 2026 CVS Health Declares Quarterly Dividend: A Commitment to Shareholder Value CVS Health has declared a quarterly dividend of $0.665 per share, payable on August 3, 2026, underscoring its commitment to delivering shareholder value. With a strong presence in the healthcare sector, CVS continues to enhance access to quality care while balancing growth and investor returns.

July 06, 2026 CVS Health Corp to Announce Second Quarter 2026 Earnings CVS Health is set to announce its second quarter 2026 earnings on August 5, 2026, during a conference call. The event will provide critical insights into the company's financial health and ongoing healthcare initiatives, reflecting its commitment to simplifying healthcare access for millions.

June 25, 2026 CVS Health Foundation Invests $1 Million in Greater Hartford Nonprofits The CVS Health Foundation has announced a $1 million investment to support 20 organizations in Greater Hartford, focusing on healthcare access, food security, and housing stability. Notable grantee ImmaCare will expand its services for individuals experiencing homelessness. This initiative reflects CVS's ongoing commitment to improving community health in Connecticut.

June 25, 2026 CVS Health Foundation Invests $1 Million in Rhode Island Nonprofits CVS Health Foundation has announced a $1 million investment to support 20 Rhode Island nonprofits addressing critical health needs. This funding aims to enhance community health through initiatives focusing on healthcare access, food security, and housing stability.

June 22, 2026 CVS Health Expands GLP-1 Support: A Comprehensive Approach to Increased Access and Affordability CVS Health has launched an initiative to improve access to GLP-1 medications, providing affordable pricing and comprehensive support for patients. By leveraging its pharmacy network and MinuteClinic services, CVS aims to help patients manage costs and side effects, ensuring adherence to therapy for better health outcomes.

May 29, 2026 CVS Health Earns Recognition for AI-Driven Innovations in Patient Care CVS Health has received the 2026 AI Impact Award from Newsweek for its AI-driven prescription interpretation technology, which enhances medication safety. The integration of AI in pharmacy workflows is designed to free up clinician time, allowing for improved patient support and faster prescription processing.

May 28, 2026 CVS Health Announces Launch of Aetna Mental Health On Demand CVS Health's Aetna is set to launch the Mental Health On Demand service in January 2027, providing real-time access to licensed clinicians for members aged 13 and older. This initiative aims to bridge gaps in mental health care and enhance support for individuals facing challenges in accessing treatment.

May 28, 2026 CVS Health Expands AI-Powered Call Center Solutions in Partnership with Salesforce CVS Health has expanded its partnership with Salesforce to enhance call center solutions using AI technology. This initiative aims to streamline member interactions, improve efficiency, and provide personalized care through integrated data resources.

May 28, 2026 CVS Health Expands Access to GLP-1 Weight Management Medications CVS Health expands its coverage for GLP-1 weight management medications, reintroducing Zepbound and removing the block on Foundayo. These changes aim to improve affordability and access for members, reflecting CVS's commitment to addressing rising prescription drug costs.

May 26, 2026 CVS Health Corp: Aetna Unveils AI-Driven Claims Processing Enhancements Aetna has launched its AI-powered Claims Assist Manager to improve claims processing efficiency in the healthcare sector. This innovation aims to reduce administrative burdens and accelerate payment timelines for providers, reflecting Aetna's commitment to digital transformation in healthcare.

May 21, 2026 CVS Health Partners to Launch Senior Affordable Housing in New Jersey CVS Health, in partnership with local agencies, launched The Mews at St. Mary, a new 75-unit affordable housing project for seniors in New Jersey. The initiative aims to tackle housing insecurity and provide essential health and wellness services to residents.

May 20, 2026 CVS Health Reaffirms Commitment to Support Military Community CVS Health has announced its commitment to support military members and families through healthcare access, community initiatives, and economic opportunities. Collaborating with organizations, CVS aims to enhance the well-being of veterans and their families across various life stages.

May 18, 2026 CVS Health Unveils Critical Findings on Digital Health Literacy Among Older Americans CVS Health's research highlights a significant gap in digital health literacy among older Americans, with many eager to engage but facing usability challenges. The study calls for tailored digital tools and community support to improve health management for seniors.

May 14, 2026 CVS Health and WGU Collaborate to Launch Innovative Pre-Pharmacy Degree Program CVS Health collaborates with WGU to launch an online pre-pharmacy degree, providing flexible education for employees aspiring to become pharmacists. This initiative aims to tackle the pharmacist shortage and enhance career opportunities for pharmacy technicians.

May 06, 2026 CVS Health Reports Strong Q1 2026 Earnings Amidst Regulatory Challenges CVS Health reported impressive Q1 2026 earnings, with revenues reaching $100.4 billion. Despite navigating regulatory challenges, the company’s integrated healthcare model and strategic acquisitions position it for future growth.

May 06, 2026 CVS Health Reports Strong First Quarter 2026 Results and Upgrades Full-Year Guidance CVS Health's Q1 2026 results show a 6.2% revenue increase, with a notable rise in earnings per share. The company has raised its full-year guidance, reflecting strong performance across its Health Care Benefits and Pharmacy segments, despite some operational challenges.

May 05, 2026 CVS Health Expands Biosimilar Adoption to Enhance Affordability and Access CVS Health is expanding its formulary to prioritize lower-cost biosimilars, significantly reducing out-of-pocket expenses for patients. This initiative aims to enhance access to essential therapies while managing medication costs. The changes take effect on July 1, 2026, supporting CVS's commitment to affordable healthcare.

April 27, 2026 CVS Health Shines at 2026 Stevie® Awards with Gold and Silver Wins CVS Health earned Gold and Silver awards at the 2026 Stevie Awards for its innovative AI applications in healthcare. The company is recognized for its commitment to ethical data use and enhancing patient care through advanced technology.

April 24, 2026 Aetna Leads the Charge in Prior Authorization Reform Aetna has made significant improvements in the prior authorization process, achieving an 88% standardization rate and over 95% rapid approvals within 24 hours. By integrating medical and pharmacy reviews and launching bundled programs, Aetna aims to enhance patient care and streamline healthcare communication.

April 08, 2026 CVS Health's Aetna Provider Survey Unveils Optimism and Opportunities in Health Care CVS Health's inaugural Aetna Provider Survey reveals a cautiously optimistic outlook from health care providers, with a majority believing in future improvements. Key areas of focus include reducing administrative burdens, enhancing patient access, and leveraging technology for better health outcomes.

April 06, 2026 CVS Health Announces First Quarter 2026 Earnings Conference Call CVS Health will hold a conference call on May 6, 2026, to discuss its Q1 earnings and strategic direction. An audio webcast will be available for those unable to attend live. This event is crucial for stakeholders to understand CVS Health's performance and future initiatives in the health solutions market.

April 01, 2026 CVS Health Corp: Omnicare Advances Court-Supervised Sale Process CVS Health's subsidiary, Omnicare, has initiated a court-supervised sale process with GenieRx as a key partner. This move aims to realign operations while continuing to support the long-term care market with quality pharmacy services. The bidding process is set to conclude by May 2026, with a focus on maintaining high standards of care during the transition.

March 30, 2026 CVS Health Corp Launches First Pharmacy-Only Location in Chicago CVS Health has launched its first pharmacy-only location in Chicago, aiming to improve access to medications and healthcare services. This initiative is part of a broader strategy to open nearly 20 such locations nationwide, focusing on community health and personalized care.

March 18, 2026 CVS Health Declares Quarterly Dividend Amidst Strong Growth Trajectory CVS Health Corporation has declared a quarterly dividend of $0.665 per share, emphasizing its commitment to shareholder returns amid strong operational growth. With a robust presence in healthcare services, CVS continues to enhance accessibility and quality care for millions.

March 18, 2026 CVS Health Foundation Invests $2.24 Million in Charlotte's West End Community Health CVS Health Foundation's $2.24 million investment will enhance community health in Charlotte's Historic West End through the Health Zone initiative. This effort aims to improve access to healthcare and nutrition while addressing significant local health challenges.

February 10, 2026 CVS Health Corporation Reports 2025 Annual Performance: Growth Amidst Challenges CVS Health's 2025 report reveals a year of notable revenue growth across its segments, despite facing challenges like litigation costs and impairment charges. The company aims to leverage technology to enhance care delivery while navigating market pressures.

October 29, 2025 CVS Health Corp: Q3 2025 Financial Report Analysis CVS Health's Q3 2025 report shows revenues of $102.8 billion, a 7.8% year-over-year increase, despite an operating loss of $3.2 billion due to high expenses and litigation charges. The company continues to focus on integrated health services amid regulatory pressures.

July 31, 2025 CVS Health Corp. Reports Strong Q2 2025 Results Amidst Legal Challenges CVS Health Corp. posted strong Q2 2025 results with $98.91 billion in revenue, reflecting an 8.4% increase despite legal expenses. The company’s focus on health services and pharmacy benefits remains pivotal for its growth strategy. Looking ahead, CVS aims to adapt to regulatory changes while enhancing care delivery through strategic acquisitions.

May 08, 2025 CVS Health Corp: AM Best Affirms Strong Credit Ratings for Aetna Subsidiaries CVS Health's Aetna subsidiaries have received strong credit ratings from AM Best, reflecting their financial stability and operational strength despite challenges. The outlook remains stable as Aetna anticipates improvements in profitability and capital growth in 2025.

May 01, 2025 CVS Health Corp Q1 2025 Financial Report: A Strong Start Amid Challenges CVS Health's Q1 2025 report highlights significant revenue growth across all segments, with total revenues reaching $94.58 billion. The company faces challenges in Medicare memberships and regulatory changes but remains committed to operational efficiencies and enhancing consumer care.

March 12, 2025 SWOT Analysis of CVS Health Corp in 2025 This SWOT analysis of CVS Health Corp examines its key strengths, such as market leadership and a diverse service portfolio, while addressing weaknesses like integration challenges and legal risks. The analysis also highlights opportunities for growth through technological innovation and Medicare expansion, set against threats from economic conditions and regulatory changes.

February 12, 2025 CVS Health Corp. 2024 Annual Report: A Year of Strategic Adjustments and Financial Resilience CVS Health's 2024 annual report reveals a revenue increase to $372.8 billion, driven by Health Care Benefits and Pharmacy segments. Despite a drop in net income and regulatory challenges, CVS is restructuring to enhance efficiency and adapt to market changes.

November 06, 2024 CVS Health Corp's Q3 2024 Report: A Crucial Turning Point Amidst Challenges CVS Health's Q3 2024 report reveals a revenue growth of 6.3% to $95.42 billion, driven by its Health Care Benefits segment. However, a significant drop in net income highlights challenges from rising costs and utilization rates, prompting scrutiny of its operational strategies and future prospects.

August 07, 2024 CVS Health Corp. Reports Mixed Financial Results for Q2 2024 CVS Health's Q2 2024 financial report reveals a 3% revenue growth to $91.23 billion, driven by health benefits despite declines in health services. The company's balance sheet remains strong, but regulatory challenges loom ahead.

May 01, 2024 CVS Health Corp Q1 2024 Financial Report: Navigating Challenges and Seizing Opportunities CVS Health's Q1 2024 report reveals mixed results with revenue growth driven by Health Care Benefits, but net income declines due to rising costs. The company faces challenges and opportunities in various segments, with a strategic focus on enhancing service offerings.

CVS Health Announces First Quarter 2026 Earnings Conference Call

Last updated: April 06, 2026 •

Taurigo

1. Conference Call Scheduled for May 6, 2026

CVS Health Corporation (NYSE: CVS) has officially announced that it will hold a conference call to discuss its financial results for the first quarter of 2026. The call is set for Wednesday, May 6, 2026, at 8:00 a.m. ET, offering analysts and investors an opportunity to gain insights into the company’s performance and strategic direction.

2. Audio Webcast Available

For those unable to join the live call, CVS Health will provide an audio webcast of the event. This broadcast will be accessible on the Investor Relations section of the CVS Health website at investors.cvshealth.com. Following the live event, the webcast will be archived for a period of one year, allowing stakeholders to review the discussion at their convenience.

3. CVS Health's Position in the Health Solutions Market

As of December 31, 2025, CVS Health has established itself as a leading health solutions company. The company operates approximately 9,000 retail locations across the United States and manages more than 1,000 walk-in and primary care medical clinics. Additionally, CVS Health is recognized as a top pharmacy benefits manager, serving around 87 million plan members. This extensive network highlights CVS Health's commitment to providing comprehensive health services.

Furthermore, CVS Health serves over 37 million individuals through various health insurance products, including traditional, voluntary, and consumer-directed plans. Notably, the company offers highly rated Medicare Advantage plans and a prominent standalone Medicare Part D prescription drug plan. This diverse portfolio underscores CVS Health’s dedication to enhancing access to quality care and improving patient outcomes.

4. Commitment to Integrated Health Solutions

CVS Health emphasizes its integrated model, which leverages personalized and technology-driven services. This approach aims to connect consumers with better health solutions, ultimately driving down costs and improving overall health outcomes. As the company prepares to release its first quarter financial results, stakeholders will be keen to assess how these efforts translate into measurable growth and profitability.

5. Looking Ahead

The upcoming earnings conference call represents a pivotal moment for CVS Health, as it will provide insights into the company's financial health and future strategies in a rapidly evolving healthcare landscape. Investors and analysts will be closely monitoring the results to gauge the effectiveness of CVS Health's initiatives and their impact on the company's market position.

In summary, CVS Health is poised to share crucial updates regarding its first quarter performance on May 6, 2026, as it continues to build a world of health around every consumer.

Original press release

You may also be interested in: